✦ LIBER ✦

Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial

✍ Scribed by Aimilia Pelekanou; Theodora Kanni; Athina Savva; Maria Mouktaroudi; Maria Raftogiannis; Antigone Kotsaki; Evangelos J. Giamarellos-Bourboulis

Book ID: 111244570
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 158 KB
Volume: 19
Category: Article
ISSN: 0906-6705
DOI: 10.1111/j.1600-0625.2009.00967.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label phase II study of the safe

An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa

✍ E.J. Giamarellos-Bourboulis; E. Pelekanou; A. Antonopoulou; H. Petropoulou; F. B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Efficacy and safety of adalimumab for mo

Efficacy and safety of adalimumab for moderate to severe hidradenitis suppurativa: Results from the open-label phase of a 52-week phase II, randomized, study

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Long-term efficacy and safety of etanerc

Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial

✍ Daniel J. Lovell; Edward H. Giannini; Andreas Reiff; Olcay Y. Jones; Rayfel Schn 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Long-term safety and efficacy in patient

Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: Results from a phase III open-label extension trial

✍ Aatif Husain; Steve Chung; Edward Faught; Jouko Isojarvi; Cindy McShea; Pamela D 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 395 KB

Efficacy and safety of efalizumab for sc

Efficacy and safety of efalizumab for scalp psoriasis: Results from a prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Long-term efficacy and safety of adalimu

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL

✍ Kenneth Gordon; Kim Papp; Yves Poulin; Yihua Gu; Stephen Rozzo; Eric H. Sasso 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 347 KB